XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Initial Public Offering
Common Stock
Common Stock
Initial Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
Initial Public Offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total Stockholders' Equity (Deficit)
Total Stockholders' Equity (Deficit)
Initial Public Offering
Noncontrolling Interest
Convertible Preferred Stock Seed-1, Seed-2, Series A-1, Series A-2, Series B, Series C, Series D, Series E
Convertible Preferred Stock Seed-1, Seed-2, Series A-1, Series A-2, Series B, Series C, Series D, Series E
Initial Public Offering
Class A - Common Stock
Class A - Common Stock
Initial Public Offering
Class B - Common Stock
Class B - Common Stock
Initial Public Offering
Temporary equity, Balance at Dec. 31, 2019 $ 121,156                     $ 121,156          
Temporary equity, Balance, Shares at Dec. 31, 2019 25,483,182                     25,483,182          
Balance at Dec. 31, 2019 $ (73,097)       $ 4,512     $ (77,609) $ (73,097)                
Balance, Shares at Dec. 31, 2019     7,289,571                            
Repurchase of convertible preferred stock $ (12,852)                     $ (12,852)          
Repurchase of convertible preferred stock, Shares (2,246,886)                     (2,246,886)          
Repurchase of convertible preferred stock $ (8,801)       (5,578)     (3,223) (8,801)                
Issuance of convertible preferred stock $ 52,409                     $ 52,409          
Issuance of convertible preferred stock, Shares 4,522,645                     4,522,645          
Exercise of common stock options $ 518       563     (45) 518                
Exercise of common stock options, Shares 465,668   466,211                            
Stock based compensation $ 1,006       1,006       1,006                
Comprehensive loss:                                  
Foreign currency translation 210           $ 210   210                
Net loss (31,085)             (31,085) (31,085)                
Comprehensive loss (30,875)           210 (31,085) (30,875)                
Temporary equity, Balance at Dec. 31, 2020 $ 160,713                     $ 160,713          
Temporary equity, Balance, Shares at Dec. 31, 2020 27,758,941                     27,758,941          
Balance at Dec. 31, 2020 $ (111,249)       503   210 (111,962) (111,249)                
Balance, Shares at Dec. 31, 2020     7,755,782                            
Conversion of convertible preferred stock in connection with the initial public offering   $ 160,713       $ 160,713       $ 160,713     $ (160,713)        
Conversion of convertible preferred stock in connection with the initial public offering, Shares                         (27,758,941)   27,351,633   407,308
Exercise of common stock options $ 2,291       2,291       2,291                
Exercise of common stock options, Shares 1,101,539   910,015                     178,402      
Conversion of common stock in connection with the initial public offering, Shares       (8,665,797)                     6,396,951   2,268,846
Exercise of warrants $ 40       40       40                
Exercise of warrants, Shares                           24,242      
Issuance of common stock in connection with the initial public offering, net of underwriters' discount   $ 325,263       $ 325,263       $ 325,263              
Issuance of common stock in connection with the initial public offering, net of underwriters' discount, Shares                             7,906,250    
Cost of initial public offering (3,678)       (3,678)       (3,678)                
Share issued in business combinations 102,888       102,888       102,888                
Share issued in business combinations, Shares                           2,100,660      
Noncontrolling interest acquired in business combination 1,036                   $ 1,036            
Donated common stock 2,226       2,226       2,226                
Donated common stock, Shares                           40,266      
Stock based compensation 7,395       7,395       7,395                
Comprehensive loss:                                  
Foreign currency translation (61)           (61)   (61)                
Net loss (61,381)             (61,379) (61,379)   (2)            
Comprehensive loss (61,442)           (61) (61,379) (61,440)   (2)            
Balance at Dec. 31, 2021 425,483       597,641   149 (173,341) 424,449   1,034            
Balance, Shares at Dec. 31, 2021                           43,998,404   2,676,154  
Vesting of restricted stock units,shares                           72,968      
Exercise of common stock options $ 3,715       3,715       3,715                
Exercise of common stock options, Shares 682,958                         684,916      
Other common stock issued $ 281       281       281                
Other common stock issued, Shares                           5,577      
Donated common stock 2,272       2,272       2,272                
Donated common stock, Shares                           60,399      
Stock based compensation 19,172       19,172       19,172                
Comprehensive loss:                                  
Foreign currency translation (81)           (121)   (121)   40            
Net loss (76,009)             (76,025) (76,025)   16            
Comprehensive loss (76,090)               (76,146)   56            
Balance at Dec. 31, 2022 $ 374,833       $ 623,081   $ 28 $ (249,366) $ 373,743   $ 1,090            
Balance, Shares at Dec. 31, 2022                           44,822,264   2,676,154